Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Clean Biologics is a leading European contract development and manufacturing organization (CDMO) and contract testing organization (CRO) providing GMP-compliant development, production, and quality control services for biopharmaceuticals, including viral vaccines, oncolytic viruses, therapeutic proteins, monoclonal antibodies, and cell and gene therapies. The company supports clinical trials up to Phase 3, with a strong focus on viral and biological safety testing. It has experienced significant growth through acquisitions and capacity expansion, positioning it in a global market driven by increased biopharma R&D spending and regulatory requirements for quality control.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Clean Biologics.